News | October 23, 2013

St. Luke’s Medical Center Offers Molecular Breast Imaging

Technology provides accurate identification of tumors in women with dense breasts, implants

mammography systems nuclear imaging st. luke's discovery nm 750b GE healthcare
October 23, 2013 — St. Luke’s Medical Center is the first hospital in the Texas Medical Center to offer a molecular breast imaging (MBI) device that is sensitive enough to detect tiny tumors.  GE Healthcare’s Discovery NM 750b is designed to help improve detection of breast cancer, even in women with dense breasts where results of mammography may be inconclusive.
 
“The Discovery system is an important advancement in the early detection and diagnosis of breast cancer, but for women with dense breasts, it could truly be a lifesaver,” said Eric Ladwig, operations manager, nuclear medicine, St. Luke’s Medical Center. “Women with dense breasts have an increased risk of breast cancer and this condition can impact the quality of a traditional mammogram. MBI is not affected by breast density, resulting in a clear image and great confidence that the patient is cancer free or truly needs to have a biopsy.”
 
MBI is a comfortable examination, as only light immobilization pressure is required during studies versus a traditional mammography.
 
During an MBI procedure with Discovery, a patient receives a tracer injection that locates metabolically active tumors by blood flow. Because the tumor metabolizes the isotope to a higher degree than normal tissue, it will appear as a “hot spot” on the scan.
 
For more information: www.stlukestexas.com
 

Related Content

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
FDA Article Underscores Benefits of Adequate Breast Compression for Mammography Image Quality
News | Mammography | June 26, 2018
Inadequate breast commission played a role in up to 38 percent of mammogram image quality deficiencies, according to a...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Overlay Init